Sale!

FIP1L1-PGDFRA Gene Rearrangement Detection Test Cost

Original price was: 2,030 د.إ.Current price is: 1,830 د.إ.

-10%

The FIP1L1-PDGFRA gene rearrangement detection test is a specialized diagnostic tool used to identify the presence of a specific genetic anomaly known as the FIP1L1-PDGFRA fusion gene. This genetic rearrangement is often associated with certain types of blood disorders, including chronic eosinophilic leukemia (CEL) and other myeloproliferative diseases. The test is critical for the accurate diagnosis and management of patients suffering from these conditions, as it can guide treatment decisions, including the use of targeted therapies.

Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves sophisticated molecular techniques to detect the FIP1L1-PDGFRA gene fusion from a patient’s blood or bone marrow sample. The presence of this gene fusion is a key indicator of the disease and its identification is essential for initiating the correct treatment protocol.

The cost of the FIP1L1-PDGFRA gene rearrangement detection test at DNA Labs UAE is 1830 AED. This price reflects the complex nature of the testing process and the significant expertise required to accurately identify this genetic rearrangement. Patients undergoing this test at DNA Labs UAE can expect high-quality service, with results that are crucial for the effective management of their condition.

Description

FIP1L1-PGDFRA GENE REARRANGEMENT DETECTION Test

Test Cost: AED 1830.0

Symptoms Diagnosis: Chronic eosinophilic leukemia (CEL) and systemic mastocytosis

Test Components:

Price: AED 1830.0
Sample Condition: 4 mL (2 mL min.) whole blood / Bone marrow from 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE.
Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.

Report Delivery: Sample Mon by 11 am; Report 12 days

Method: PCR

Test Type: Pharmacogenomics

Doctor: Physician

Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information: Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.

Test Details:

The FIP1L1-PGDFRA gene rearrangement detection test is a diagnostic test used to identify a specific genetic abnormality in certain types of blood cancers, such as chronic eosinophilic leukemia (CEL) and systemic mastocytosis. This test specifically looks for a rearrangement of the FIP1L1 and PDGFRA genes, which can result in the production of a fusion protein that drives the growth and proliferation of abnormal cells.

The test typically involves analyzing a sample of blood or bone marrow to detect the presence of the FIP1L1-PDGFRA fusion gene. This can be done through various techniques, such as polymerase chain reaction (PCR) or fluorescence in situ hybridization (FISH).

The detection of the FIP1L1-PDGFRA gene rearrangement is important for diagnosing and monitoring certain blood cancers, as it can help guide treatment decisions. In particular, it can help identify patients who may benefit from targeted therapies that specifically target the abnormal fusion protein.

Test Name	FIP1L1-PGDFRA GENE REARRANGEMENT DETECTION Test
Components
Price	1830.0 AED
Sample Condition	4 mL (2 mL min.)whole blood \/ Bone marrow from 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Report Delivery	Sample Mon by 11 am; Report 12 days
Method	PCR
Test type	Pharmacogenomics
Doctor	Physician
Test Department:	MOLECULAR DIAGNOSTICS
Pre Test Information	Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Test Details	The FIP1L1-PGDFRA gene rearrangement detection test is a diagnostic test used to identify a specific genetic abnormality in certain types of blood cancers, such as chronic eosinophilic leukemia (CEL) and systemic mastocytosis. This test specifically looks for a rearrangement of the FIP1L1 and PDGFRA genes, which can result in the production of a fusion protein that drives the growth and proliferation of abnormal cells. The test typically involves analyzing a sample of blood or bone marrow to detect the presence of the FIP1L1-PDGFRA fusion gene. This can be done through various techniques, such as polymerase chain reaction (PCR) or fluorescence in situ hybridization (FISH). The detection of the FIP1L1-PDGFRA gene rearrangement is important for diagnosing and monitoring certain blood cancers, as it can help guide treatment decisions. In particular, it can help identify patients who may benefit from targeted therapies that specifically target the abnormal fusion protein.